Zosano Pharma Appoints New CMO, Fills Two New Operations Management Positions to Bolster Leadership Team
April 30, 2015 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN) announced today important leadership additions and changes with Thorsten von Stein, M.D., Ph.D. returning to...
Zosano Pharma Reports 2014 Financial Results
March 25, 2015 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle...
Zosano Pharma to Present at the 27th Annual ROTH Conference
March 03, 2015 08:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN) announced today that Vikram Lamba, Chief Executive Officer, will provide a company overview at the 27th...
Zosano Pharma Announces Pricing of Initial Public Offering
January 27, 2015 08:24 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq: ZSAN) announced today the pricing of its initial public offering of 4,500,000 shares of common stock at a price to...
Zosano Pharma and Eli Lilly and Company Enter Into Exclusive Licensing Agreement for Zosano's ZP-PTH Product Candidate
December 02, 2014 08:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif. and INDIANAPOLIS, Dec. 2, 2014 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Zosano) and Eli Lilly and Company (NYSE:LLY) today announced that they have entered into an exclusive...